Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Elisabetta Sauta, Marie Robin, Matteo Bersanelli, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 15, pp. 2827-2842
Open Access | Times Cited: 63

Showing 26-50 of 63 citing articles:

Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome
Muriel R. Battaglia, Joseph Cannova, Rafael Madero‐Marroquin, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 6, pp. 752-768
Closed Access | Times Cited: 1
Revisiting Timing and Decision Modeling for Allogeneic Hematopoietic Stem-Cell Transplantation in Myelodysplastic Syndromes
Corey Cutler
Journal of Clinical Oncology (2024) Vol. 42, Iss. 24, pp. 2843-2848
Closed Access | Times Cited: 1
Targeted therapies for myelodysplastic Syndromes/Neoplasms (MDS): current landscape and future directions
Aram Bidikian, Jan Philipp Bewersdorf, Rory M. Shallis, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 11, pp. 1131-1146
Closed Access | Times Cited: 1
Allogeneic Hematopoietic Cell Transplantation in Elderly Patients with Myelodysplastic Syndromes: Considerations and Challenges
Eduard Schulz, Steven Z. Pavletic, Alain Mina
Seminars in Hematology (2024)
Closed Access | Times Cited: 1
A retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS)
Jean Sabile, Andy Kaempf, Kaitlyn Tomic, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 10, pp. 1689-1694
Closed Access | Times Cited: 4
Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms
Tingting Yang, Baoqin Jiang, Yi Luo, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 12
Open Access | Times Cited: 4
A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias
Elena Mavridou, Anair Graciela Lema Fernandez, Carlotta Nardelli, et al.
Genes Chromosomes and Cancer (2024) Vol. 63, Iss. 4
Open Access | Times Cited: 1
Current challenges in conditioning regimens for MDS transplantation
A.B. Notarantonio, Marie Robin, Maud D’Aveni
Blood Reviews (2024) Vol. 67, pp. 101223-101223
Open Access | Times Cited: 1
Assessing the Relevance of Non-molecular Prognostic Systems for Myelodysplastic Syndrome in the Era of Next-Generation Sequencing
Marco Lincango Yupanki, Verónica Andreoli, Hernán Garcı́a Rivello, et al.
Annals of Laboratory Medicine (2024) Vol. 45, Iss. 1, pp. 44-52
Open Access | Times Cited: 1
Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations
Yü Liu, Huan-Chen Cheng, Mei Cheng, et al.
Hematology (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition
Valentina Giudice, Bianca Serio, Santa Errichiello, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 5, pp. 729-741
Open Access | Times Cited: 3
Mutational screening to improve the transplantation decision-making process in MDS
Alessia Campagna, Matteo Giovanni Della Porta
Hematology (2023) Vol. 2023, Iss. 1, pp. 73-76
Closed Access | Times Cited: 2
Comparison of the 2022 World Health Organization Classification and International Consensus Classification in Myelodysplastic Syndromes/Neoplasms
Hsin‐An Hou, Wan‐Hsuan Lee, Chien‐Chin Lin, et al.
Research Square (Research Square) (2024)
Open Access
Comparison of the Molecular International Prognostic Scoring System (IPSS-M) and Revised International Prognostic Scoring System (IPSS-R) in predicting the prognosis of patients with myelodysplastic neoplasms treated with decitabine
Nguyen Hao Quang, Minh Phuong Vu, Anh Tuấn Trần, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 2, pp. 323-328
Open Access
Diagnosis and Treatment of Myelodysplastic Syndrome in the Era of Genetic Testing
Junshik Hong
Korean Journal of Medicine (2024) Vol. 99, Iss. 1, pp. 11-16
Open Access
SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes
Michael J. Hochman, Amy E. DeZern
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 9, pp. 573-582
Closed Access
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes
Chi‐Yuan Yao, Chien‐Chin Lin, Yu‐Hung Wang, et al.
Blood Advances (2024) Vol. 8, Iss. 10, pp. 2442-2454
Open Access
Neueste Erkenntnisse zum myelodysplastischen Syndrom
Verena Petzer, Dominik Wolf‎
TumorDiagnostik & Therapie (2024) Vol. 45, Iss. 03, pp. 195-199
Closed Access
Myelodysplastic Neoplasms/Syndromes (MDS)
Marie Robin, Carmelo Gurnari
Springer eBooks (2024), pp. 669-677
Closed Access
Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities
Tariq Kewan, Maximillian Stahl, Jan Philipp Bewersdorf, et al.
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 3, pp. 138-150
Closed Access
Prophylactic Intervention for Relapse after Allogeneic Peripheral Blood Stem Cell Transplantation Improve the Survival of adult patients with Myelodysplastic Syndrome based on IPSS-M stratification
Xianmin Song, Huixian Wu, Li Shuang, et al.
Research Square (Research Square) (2024)
Open Access
Molecular alterations monitoring in myelodysplastic patients receiving an allogeneic hematopoietic stem cell transplantation after a reduced-intensity conditioning regimen
Marie Robin, Olivier Nibourel, Martin Tournaire, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 9, pp. 1309-1312
Closed Access
Clinical validation of the Ion Torrent Oncomine Myeloid Assay GX v2 on the Genexus Integrated Sequencer as a stand-alone assay for single-nucleotide variants, insertions/deletions, and fusion genes: Challenges, performance, and perspectives
Kritika Krishnamurthy, Jiani Chai, Xiaowei Liu, et al.
American Journal of Clinical Pathology (2024) Vol. 162, Iss. 5, pp. 480-491
Closed Access
Place de l’allogreffe dans les leucémies aiguës myéloblastiques et syndromes myélodysplasiques de très haut risque (SFGM-TC)
Clémence Médiavilla, Maud D’Aveni, Anne Huynh, et al.
Bulletin du Cancer (2024)
Closed Access
Elevated serum direct bilirubin is predictive of a poor prognosis for primary myelodysplastic syndrome
Ying Chen, Danqing Zhou, Chao Ma, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access

Scroll to top